Good morning, folks, and how are you today? A bit of snow has descended on the Pharmalot corporate campus as challenging meterological events continue to emerge in our scarred region. Nonetheless, we are soldiering on, helped by a needed cup of stimulation. Perhaps you would like to join us? Meanwhile, we have, once again, gathered some items of interest to help you focus and proceed with the tasks ahead. Hope your day goes well and do stay in touch...
Health Canada To Decide On Novartis Flu Vaccine (Montreal Gazette)
Cipla Cuts Prices On Three Cancer Drugs (Wall Street Journal)
Glaxo And Horizant End For Restless Legs Drug (Dow Jones)
Novartis Hopes To Have 14 New Blockbusters By 2017 (Reuters)
NYU Faces More Criticism Over Lab Rats Killed By Storm (Reuters)
Sun Pharma Pays $230M For Dusa Pharmaceuticals (LiveMint)
Merck May Not Have Shown Women Can Safely Use Bladder Drug (Bloomberg News)
Pfizer Returns EU Rights For Auxilium Dupuytren's Drug (Pharma Times)
EDITOR'S NOTE: Please check this post for updates
pic thx to nicole/mealy monster flickr